Innova Captab Ltd
Innova Captab Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Innova Captab targets 20%+ top-line growth over the next 3-4 years, aiming to double revenue as per past trends. Innova Captab aims to double its top line in the next 3 to 4 years, targeting a 20%+ annual growth trajectory.
From Innova Captab Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Innova Captab targets 20%+ top-line growth over the next 3-4 years, aiming to double revenue as per past trends.
- The Jammu facility is planned to ramp up over a 3-4 year horizon, targeting north of INR 1,400 crores revenue at 65-70% capacity utilization.
- Current Jammu revenue is around INR 120 crores for H1 FY26, targeting approximately INR 270-280 crores for full FY26, below the initial INR 400 crores estimate due to API price correction.
- CDMO business is witnessing 15% YoY growth in Q2 FY26, supported by expanding client base and product portfolio.
- Branded Generics segment shows strong growth at 31% YoY in Q2 FY26 and 43% in H1 FY26.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Innova Captab Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Innova Captab invested approximately INR480 crores in the Jammu facility.
- The Jammu plant is expected to reach 65%-70% capacity utilization within 3-4 years.
- Peak revenue potential from Jammu is estimated at north of INR1,400 crores.
- Jammu expansion is a key part of the 20%+ growth trajectory and is expected to contribute significantly to future growth.
2 more points management made on capital expenditure plans
Top-ranked in Pharmaceuticals & Biotechnology
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Innova Captab Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Innova Captab has a strong order book, which is expected to support growth in the coming months.
- The company is optimistic about sustaining growth momentum due to this robust pipeline.
- Several prominent pharmaceutical companies have completed audits and reviews at the new Jammu facility, with business operations commenced with some and advanced discussions ongoing with others.
- This strong foundation is expected to enable scale-up in the near term.
2 more points management made on order book & pipeline
Innova Captab Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹448 Cr, net profit ₹38 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Innova Captab's management said in earlier quarters
Others in Pharmaceuticals & Biotechnology this season
- Morepen Laboratories Ltd (Q2 FY26)
248 Crores . Key concall takeaways from Morepen Laboratories Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.
- Jubilant Pharmova Ltd (Q2 FY26)
Q2’FY26 revenue grew by 12% YoY to Rs. Key concall takeaways from Jubilant Pharmova Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.
- Anuh Pharma Ltd (Q2 FY26)
185.88 Cr, a -0.32% change quarter-on-quarter; 6 months ended 30/09/2025: Rs. Key concall takeaways from Anuh Pharma Ltd's Q2 FY26 earnings call — and how it…
- Themis Medicare Ltd (Q2 FY26)
Q2 FY26 Net Revenue: ₹77.99 Cr, down 33.3% YoY from ₹117.01 Cr in Q2 FY25 (Page 8) . Key concall takeaways from Themis Medicare Ltd's Q2 FY26 earnings call…
Frequently Asked Questions
What were Innova Captab Ltd Q2 FY26 results?
Innova Captab targets 20%+ top-line growth over the next 3-4 years, aiming to double revenue as per past trends. Innova Captab aims to double its top line in the next 3 to 4 years, targeting a 20%+ annual growth trajectory.
What is Innova Captab Ltd share price analysis?
Innova Captab Ltd currently shows a neutral. The stock trades at a P/E of 38.5 with a market cap of ₹5,408 Cr. Investors should review the full earnings analysis for detailed insights.
Is Innova Captab Ltd planning capital expenditure?
Innova Captab invested approximately INR480 crores in the Jammu facility.
Keep Innova Captab Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.